American hospitals vary greatly in what they offer to birthing parents when a stillbirth occurs during labor or delivery.

A Michigan Medicine-led study found that transgender individuals show similar rates of severe parental morbidity and preterm birth and lower rates of cesarean delivery when compared to cisgender people.

As guest editor for a themed journal issue, Lori Pierce helps highlight the multiple factors that can make cancer care and prevention more equitable and reduce the burden of this disease for all

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.

Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment, also finding a way to deliver immunotherapy’s cancer-killing impact without the unwelcome side effect.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

A team developed a new approach for combining microbiome data together while overcoming the noise introduced by the different techniques used in each study into a tool they dubbed MaLiAmPi (Maximum Likelihood Amplicon Pipeline).

Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.

The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.

A Michigan Medicine urogynecologist discusses what urinary tract infections are, how they are treated and what new research is on the horizon.

Researchers from the University of Michigan Health Rogel Cancer Center have developed a monitoring system using a research genetics program to trigger alerts about cancer patients suspected to have the DPYD gene variant.

The current IVF recommendation is for transgender patients to stop taking gender-affirming hormones before the procedure, which can be costly and life changing. Now, a team of researchers are diving in further to investigate what the best recommendations should be based on more evidence.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.